







 
 
  



<HTML>
<HEAD>
<TITLE>
	
	The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer -- Guo et al. 278 (7): 4385 -- Journal of Biological Chemistry</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>




	<!-- has inhead tag -->
	
		 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
		
	
		<style type="text/css"><!--
table.content_box_outer_table {
	padding-left:10px;
	padding-bottom:5px;
	padding-top:0px;
	padding-right:0px;
	}

table.content_box_outer_table_in_sidebar_frame {
	padding-left:10px;
	padding-bottom:0px;
	padding-top:10px;
	padding-right:10px;
	}

table.content_box_inner_table {
	background-color:#f0f0f0;
	font-family:Verdana,Arial,Helvetica,sans-serif;
	font-size:65%;
	padding-top:0px;
	padding-left:0px;
	padding-right:0px;
	padding-bottom:5px;
	}

table.content_box_pdfinframes {
	padding-top:0px;
	padding-left:0px;
	padding-right:0px;
	padding-bottom:4px;
	}

td.content_box_title_highlight {
	font-family:"Trebuchet MS",Verdana,Arial,Helvetica,sans-serif;
	font-style:italic;
	color:#ffffff;
	background-color:#006699;
	font-size:120%;
	font-weight:bold;
	text-align:center;
	padding:1px;
	vertical-align:middle;
	}

td.content_box_title {
	font-family:"Trebuchet MS",Verdana,Arial,Helvetica,sans-serif;
	font-style:italic;
	color:#ffffff;
	background-color:#828282;
	font-size:120%;
	font-weight:bold;
	padding:1px;
	text-align:center;
	vertical-align:middle;
	}

td.content_box_space_between_sections {
	padding-top:2px;
	}

td.content_box_arrow {
	text-align:right;
	padding-left:5px;
	padding-right:0px;
	padding-top:0px;
	padding-bottom:3px;
	}

td.content_box_item {
	text-align:left;
	vertical-align:top;
	padding-left:3px;
	padding-right:5px;
	padding-top:0px;
	padding-bottom:3px;
	}

td.content_box_pdfinframes_citation_cell {
	background-color:#ffffff;
	border:1px #000000 solid;
	padding:3px;
	font-family:Verdana,Arial,Helvetica,sans-serif;
	font-size:65%;
	text-align:left;
	}


font.openaccess {
	font-weight:bold;
	padding-left:3px;
	padding-right:3px;
	background-color:#ffffff;
	}
font.openaccess_open {
	color:#000000;
	}
font.openaccess_access {
	color:#cc0000;
	}
font.openaccess_oa {
	}
.content_box_openaccess_title {
	text-align:center;
	white-space:nowrap;
	background-color:#BABABA;
	}

--></style>

		
	<script language="javascript">
		<!-- 
	function popwin(url,wid,hei,fromtop,fromleft) {
		var winPref = "channelmode=no,toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=auto,resizable=no,width=" + wid + ",height=" + hei + ",top=" + fromtop + ",left=" + fromleft;
		window.open(url, "popwin", winPref);
	}
	// -->
	</script>

<meta name="robots" content="nofollow">
<META NAME="ROBOTS" CONTENT="NOARCHIVE"> 

</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A HREF="/cgi/adclick/?ad=4220&adclick=true&url=http://www.ebioscience.com"><IMG SRC="/adsystem/graphics/jbc/1094675101.gif?ad=4220&adview=true" ALT="eBioscience" BORDER="1" WIDTH="220" HEIGHT="40"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol278/issue7/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE=""><INPUT TYPE="hidden" NAME="sortspec" VALUE="relevance"><TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	





	
	
	
	 

	


	
	




				<FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	


<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>



















	






	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/C200679200v1">doi:10.1074/jbc.C200679200</A> on December 19, 2002</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 278, Issue 7, 4385-4388, February 14, 2003</FONT><BR>
		
	

 

 
	  
		
	
		<table class="content_box_outer_table"
		 
			
				
					align="right"
				
			
		>
			<tr>
			<td>
	

<!-- beginning of inner table -->
	<table class="content_box_inner_table">
<!-- citation -->

	
		




	

	

	
		
			
<tr><td class="content_box_title_highlight" colspan="2">This Article</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				
				<strong><a href="/cgi/content/abstract/278/7/4385">
				Abstract</a></strong>
				 					<img alt="" width="32" height="7" border="0" src="/icons/shared/toc/free.gif">
				
	
				</td></tr>
			
		
		
	

	
	
	

	
	
	


	
	
	

	
	
	

	
	
	

	
	
	

	
		
	

	

	
		
			
		
	

	

	
	 

	
	 

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
		<strong>
		
		
		
			
				
				
					<a href="/cgi/reprint/278/7/4385">
		<strong>Full Text</strong> (PDF)</a>
				
			
		
		</strong>
		</td></tr>
	
	

	
	
	

	
	
	

	
	





	
		

	
		

	
		
		

			


	

			

			
		
	

			
	  
	

			

			

			
	
	

	
		
	









	
		
	
		
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item"><strong>
			All Versions of this Article:<br>
		
			
					278/7/4385
				
		&nbsp;&nbsp;&nbsp;<font color="#006699"><em>most recent</em></font><br>
	

	
		
		
			<a href="/cgi/content/short/C200679200v1">
					C200679200v1</a>
			
		</strong></td></tr>
	

	





	

	 

	

	
	
		  
    

	







		
	
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;278/7/4385&return_type=article&return_url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385">
				Alert me when this article is cited</a></strong>
			</td></tr>
	

		
		

		
		

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/ctalert?alertType=correction&addAlert=correction&saveAlert=no&correction_criteria_value=278/7/4385&return_type=article&return_url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385">
				Alert me if a correction is posted</a></strong>
			</td></tr>
		










			
		
			
			
			
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
					<strong><a href="/cgi/citemap?id=jbc;278/7/4385">
					Citation Map</a></strong>
				</td></tr>
		
	

			
			
<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr><tr><td class="content_box_title" colspan="2">Services</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/mailafriend?url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385&title=The+Fourth+Transmembrane+Segment+Forms+the+Interface+of+the+Dopamine+D2+Receptor+Homodimer">
				Email this article to a friend</a></strong>
			</td></tr>
			
			


	

	

		
		



			
			
			
		
	

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
		<strong>
		<a href="/cgi/search?qbe=jbc;C200679200&journalcode=jbc&minscore=5000">
		Similar articles in this journal</a>
		</strong>
		</td></tr>

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/external_ref?access_num=12496294&link_type=MED_NBRS">
				Similar articles in PubMed</a></strong>
			</td></tr>
		
	


		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/etoc">
				Alert me to new issues of the journal</a></strong>
			</td></tr>
		

		
		
	

		
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
			<strong><a href="/cgi/citmgr?gca=jbc;278/7/4385">
			Download to citation manager</a></strong>
			</td></tr>
		
		
	


	
		
	

	


	
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="#otherarticles">
				Cited by other online articles</a></strong>
			</td></tr>
		
	
		
	

	

		


	
	
	
		

	

	






	
		
<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr><tr><td class="content_box_title" colspan="2">PubMed</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/external_ref?access_num=12496294&link_type=PUBMED">
				PubMed Citation</a></strong>
			</td></tr>
		
	

	
		
		
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
							<strong><a target="_blank" href="/cgi/external_ref?access_num=Guo+W&link_type=AUTHORSEARCH">
							Articles by Guo, W.</a></strong>
						</td></tr>
				
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
							<strong><a target="_blank" href="/cgi/external_ref?access_num=Javitch+JA&link_type=AUTHORSEARCH">
							Articles by Javitch, J. A.</a></strong>
						</td></tr>
				
			
		

		
	






	






	
		

	

		
			
		











	




	</td></tr></table>
</td></tr></table> 

	











 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>
ACCELERATED PUBLICATION<BR>
</FONT>

    The Fourth Transmembrane Segment Forms the Interface of the
Dopamine D2 Receptor Homodimer<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>




<STRONG>
<NOWRAP>
Wen 
Guo<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BOTTOM ALT="Dagger "></SUP>,<WBR>
Lei 
Shi<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BOTTOM ALT="Dagger "></SUP>, and<WBR>
Jonathan A. 
Javitch<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BOTTOM ALT="Dagger "></SUP><SUP>&#167;</SUP><A HREF="#FN154"><SUP>&#182;</SUP></A>
</NOWRAP>
</STRONG>
<P>
From the <SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BOTTOM ALT="Dagger "></SUP>&nbsp;Center for Molecular Recognition,
<SUP>&#167;</SUP>&nbsp;Departments of Psychiatry and Pharmacology, Columbia
University College of Physicians and Surgeons, New York, New
York 10032
<P>
Received for publication, December 6,&nbsp;2002
<P>







    
	
	    
	
	    
		
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS AND DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Considerable evidence suggests that
G-protein-coupled receptors form homomeric and heteromeric dimers
<I>in vivo</I>. Unraveling<SUP> </SUP>the structural mechanism for cross-talk
between receptors in a<SUP> </SUP>dimeric complex must start with the
identification of the presently<SUP> </SUP>unknown dimer interface. Here, by using
cysteine cross-linking,<SUP> </SUP>we identify the fourth transmembrane segment
(TM4) as a symmetrical<SUP> </SUP>dimer interface in the dopamine D2 receptor.
Cross-linking is<SUP> </SUP>unaffected by ligand binding, and ligand binding and
receptor<SUP> </SUP>activation are unaffected by cross-linking, suggesting that
the<SUP> </SUP>receptor is a constitutive dimer. The accessibility of adjacent<SUP> </SUP>residues in TM4, however, is affected by ligand binding, implying<SUP> </SUP>that
the interface has functional<SUP> </SUP>significance.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS AND DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>G-protein-coupled receptors
(GPCRs)<SUP>1</SUP> comprise a large
superfamily of receptors that couple binding of a diverse group of
ligands<SUP> </SUP>to activation of heterotrimeric G-proteins (<A HREF="#B1">1</A>). A number of<SUP> </SUP>class C GPCRs have been shown to form dimers in the plasma membrane,<SUP> </SUP>including the calcium-sensing receptor (<A HREF="#B2">2</A>), the GABA<SUB>B</SUB>
receptor<SUP> </SUP>(<A HREF="#B3">3-5</A>), and the metabotropic glutamate receptors (<A HREF="#B6">6</A>). In the<SUP> </SUP>case of the GABA<SUB>B</SUB> receptor, heterodimerization is essential
for<SUP> </SUP>proper trafficking to the cell surface (<A HREF="#B7">7</A>). Furthermore, the<SUP> </SUP>evidence supports a scenario in which the binding of GABA to the<SUP> </SUP>R1
subunit causes the R2 subunit to bind to and activate G-protein<SUP> </SUP>(<A HREF="#B8">8</A>, <A HREF="#B9">9</A>).
In addition, mounting evidence supports the hypothesis<SUP> </SUP>that many class
A rhodopsin-like receptors, including the dopamine<SUP> </SUP>D2 receptor (D2R</A>)
(<A HREF="#B10">10-13</A>), in membrane and in some cases in detergent,<SUP> </SUP>are dimeric as
well (reviewed in Refs. <A HREF="#B14">14-16</A>).
</P>
<P>Unraveling the structural mechanism for cross-talk between receptors in
a dimeric complex must start with the identification<SUP> </SUP>of the presently
unknown dimer interface. Two hypotheses have<SUP> </SUP>been proposed for GPCR</A>
dimerization: domain swapping and contact<SUP> </SUP>dimerization (<A HREF="#B17">17</A>, <A HREF="#B18">18</A>),
although recent experimental results<SUP> </SUP>seem inconsistent with domain
swapping being the dominant form<SUP> </SUP>of dimerization (<A HREF="#B19">19</A>, <A HREF="#B20">20</A>).
</P>
<P>Synthetic peptides of TM6 block dimerization and activation of the
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>2</SUB>-adrenergic receptor (<A HREF="#B21">21</A>), and it has been suggested<SUP> </SUP>that the G<I>XXX</I>G motif in TM6 may be involved in dimerization
of<SUP> </SUP>this receptor, although this motif is not highly conserved in<SUP> </SUP>other
family A GPCRs. Synthetic peptides of TM6 and of TM7 also<SUP> </SUP>blocked
dimerization of the D2 receptor (D2R</A>) (<A HREF="#B12">12</A>). Although<SUP> </SUP>these findings
were specific to these particular synthetic peptides,<SUP> </SUP>the data do not
necessarily establish TM6 and/or TM7 as the dimer<SUP> </SUP>interface, as the
peptide-receptor interactions might modulate<SUP> </SUP>the ability of the
receptor to form dimers at a different interface.<SUP> </SUP>In addition, if the
receptors form higher order oligomers, multiple<SUP> </SUP>interfaces must<SUP> </SUP>exist.
</P>
<P>Computational studies have proposed a number of different potential
interfaces (<A HREF="#B22">22-24</A>), but these have not yet been experimentally<SUP> </SUP>verified. By using cysteine cross-linking, we have now explored<SUP> </SUP>the
possibility that the D2R</A> exists as a dimer or higher order<SUP> </SUP>oligomer in
the plasma membrane. We show that the D2R</A> is at least<SUP> </SUP>a homodimer, with
the extracellular end of TM4 at a symmetrical<SUP> </SUP>dimer<SUP> </SUP>interface.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS AND DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Numbering of Residues and Site-directed
Mutagenesis--</I>

Residues are numbered according to their positions in
the human dopamine D2<SUB>short</SUB> receptor sequence. We also index
residues<SUP> </SUP>relative to the most conserved residue in the TM</A> in which it
is<SUP> </SUP>located (<A HREF="#B32">32</A>). The most conserved residue is assigned the position<SUP> </SUP>index "50," <I>e.g.</I> Trp-160<SUP>4.50</SUP>, and therefore
Val-159<SUP>4.49</SUP> and Val-161<SUP>4.51</SUP>. Mutations were
generated as described previously (<A HREF="#B30">30</A>) and<SUP> </SUP>were confirmed by DNA
sequencing. Mutants are named as (wild-type<SUP> </SUP>residue)-(residue
number)<SUP>position index</SUP> (mutant residue), where the residues
are given in the single-letter<SUP> </SUP>code.



    

    


<P><I>Transfection--</I>

The cDNA encoding the dopamine
D2<SUB>short</SUB> receptor or the appropriate cysteine mutant was
epitope-tagged at the amino terminus<SUP> </SUP>with the cleavable
influenza-hemagglutinin signal sequence followed<SUP> </SUP>by the FLAG epitope
(DYKDDDK) and inserted into the bicistronic<SUP> </SUP>expression vector pcin4
(<A HREF="#B30">30</A>), creating SFD2-pcin4. Cells were<SUP> </SUP>maintained, and stable
transfections were performed as described<SUP> </SUP>previously (<A HREF="#B30">30</A>). For
coimmunoprecipitation studies, an NH<SUB>2</SUB>-terminal<SUP> </SUP>signal
sequence Myc epitope-tagged D2R</A> was created and subcloned<SUP> </SUP>in the
bicistronic vector pCIhyg (<A HREF="#B33">33</A>), creating SMD2-pcihyg.<SUP> </SUP>Double stable
cells were created by transfecting stable cells<SUP> </SUP>expressing SFD2-pcin4
with the SMD2-pcihyg construct and selecting<SUP> </SUP>with 250&nbsp;&#181;g/ml
hygromycin. EM4 cells, an adherent clonal line<SUP> </SUP>of HEK 293&nbsp;cells, were
maintained as described (<A HREF="#B33">33</A>) and were<SUP> </SUP>used for cAMP experiments (<A HREF="#B34">34</A>).



    

    


<P><I>Cross-linking--</I>

HEK 293&nbsp;cells or EM4 cells stably transfected
with the appropriate D2R</A> construct were washed and then reacted for 10&nbsp;min at<SUP> </SUP>room temperature with the stated concentrations of copper
sulfate<SUP> </SUP>and 1,10-phenanthroline (CuP</A>) as described previously (<A HREF="#B35">35</A>).<SUP> </SUP>Phenanthroline was used at a 4-fold molar excess over copper.<SUP> </SUP>After
removal of the CuP</A> solution, the cells were washed twice<SUP> </SUP>with 4&nbsp;ml of
PBS</A> and reacted for 20&nbsp;min at room temperature with<SUP> </SUP>10&nbsp;m<font size=-1>M</font>
<I>N</I>-ethylmaleimide (NEM</A>) in PBS++ buffer (11&nbsp;m<font size=-1>M</font>
Na<SUB>2</SUB>HPO<SUB>4</SUB>, 154<SUP>&nbsp;</SUP>m<font size=-1>M</font> NaCl, 2.7&nbsp;m<font size=-1>M</font> KCl, 1&nbsp;m<font size=-1>M</font> MgCl<SUB>2</SUB>, 0.1&nbsp;m<font size=-1>M</font> CaCl<SUB>2</SUB>) to block free sulfhydryl<SUP> </SUP>groups. The
cells were scraped into PBS++/PI buffer (PBS++ supplemented<SUP> </SUP>with 2&nbsp;&#181;g/ml Pefabloc, 2&nbsp;&#181;g/ml aprotinin, 1&nbsp;&#181;g/ml leupeptin, 1<SUP>&nbsp;</SUP>&#181;g/ml pepstatin A, and 10&nbsp;m<font size=-1>M</font> NEM</A>) and pelleted at
800&nbsp;&#215;&nbsp;<I>g</I> for<SUP> </SUP>5&nbsp;min at 4&nbsp;&#176;C. The pellet was suspended
and incubated in 0.5%<SUP> </SUP>dodecyl maltoside (DM</A>) for 60&nbsp;min at 4&nbsp;&#176;C.
The mixture was centrifuged<SUP> </SUP>at 20,000&nbsp;&#215;&nbsp;<I>g</I> for 30&nbsp;min
at 4&nbsp;&#176;C. Twenty &#181;l of extract was mixed<SUP> </SUP>with an equal volume of
4&#215; Laemmli sample buffer without reducing<SUP> </SUP>agent.



    

    


<P><I>Coimmunoprecipitation--</I>

HEK 293&nbsp;cells, stably transfected
with SFD2 or SMD2 or both were reacted with CuP</A> and solubilized in DM</A>
as above. To 0.3&nbsp;ml<SUP> </SUP>of DM</A> extracts was added 1.5&nbsp;&#181;l anti-FLAG M1
mouse monoclonal<SUP> </SUP>antibody (Sigma), and the mixture was incubated for
1&nbsp;h on ice.<SUP> </SUP>Thirty &#181;l of prewashed rec-protein G-Sepharose
(<a href="/cgi/inline?Zymed">Zymed Laboratories<SUP> </SUP>Inc.</a>) were added, and the mixture
was incubated 1&nbsp;h at 4&nbsp;&#176;C, washed<SUP> </SUP>four times in 1&nbsp;ml of lysis
buffer, and eluted at room temperature<SUP> </SUP>for 30&nbsp;min in 50&nbsp;&#181;l of 2&#215;
Laemmli sample buffer without reducing<SUP> </SUP>agent.



    

    


<P><I>Immunoblotting--</I>

Samples were applied to 1.5-mm, 10-well
7.5% acrylamide gels prepared and run according to Laemmli (<A HREF="#B36">36</A>). The
bands were<SUP> </SUP>transferred to a polyvinylidene difluoride membrane
(Millipore),<SUP> </SUP>which was blocked for 1&nbsp;h at room temperature in 5%
nonfat milk,<SUP> </SUP>1% bovine serum albumin, 0.1% Tween 20&nbsp;in TBS (50&nbsp;m<font size=-1>M</font> Tris-HCl,<SUP> </SUP>150&nbsp;m<font size=-1>M</font> NaCl, pH 7.4). To detect
FLAG-D2R, we typically incubated<SUP> </SUP>the blot with an anti-FLAG rabbit
polyclonal antibody (Sigma)<SUP> </SUP>diluted 1:10,000 in blocking buffer for
1&nbsp;h at room temperature.<SUP> </SUP>For Myc-D2R we incubated with an anti-Myc
rabbit polyclonal (Santa<SUP> </SUP>Cruz Biotechnology) diluted 1:400 in blocking
buffer for 1&nbsp;h at<SUP> </SUP>room temperature. The membranes were washed
three times for 10<SUP>&nbsp;</SUP>min in TBS containing 0.1% Tween 20,&nbsp;incubated in
horseradish<SUP> </SUP>peroxidase-conjugated anti-rabbit-antibody (Santa Cruz
Biotechnology),<SUP> </SUP>diluted 1:15,000 in blocking buffer for 1&nbsp;h at
room temperature,<SUP> </SUP>washed three times for 10&nbsp;min with TBS containing
0.1% Tween,<SUP> </SUP>and reacted with ECL-Plus reagent (<a href="/cgi/inline?Amersham">Amersham</a>
Biosciences). Luminescence<SUP> </SUP>was detected and quantitated on a
FluorChem 8000&nbsp;(Alpha Innotech<SUP> </SUP>Corporation).



    

    


<P><I>[<SUP>3</SUP>H]N-Methylspiperone Binding and cAMP
Assay--</I>

Intact cells were harvested for binding and
[<SUP>3</SUP>H]<I>N</I>-methylspiperone (PerkinElmer Life
Sciences) binding was performed as described<SUP> </SUP>previously (<A HREF="#B30">30</A>).
EM4 cells stably expressing the D2R</A> mutants<SUP> </SUP>were used for assay of cAMP
accumulation as described previously<SUP> </SUP>(<A HREF="#B37">37</A>) except that 10&nbsp;&#181;<font size=-1>M</font> forskolin was used to stimulate adenylyl<SUP> </SUP>cyclase, and
increasing concentrations of dopamine were used to<SUP> </SUP>activate the D2R</A> and
inhibit the forskolin-stimulated<SUP> </SUP>cyclase.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS AND DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS AND DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Our strategy to identify residues forming the dimer interface in
the D2R</A> was to use cysteine cross-linking. Thus, it was essential<SUP> </SUP>to
develop a system that would allow non-cross-linked receptor<SUP> </SUP>to run as a
monomer on non-reducing SDS-PAGE. In preliminary experiments<SUP> </SUP>using
transient transfection of D2R</A>, we found, consistent with<SUP> </SUP>previous
reports (<A HREF="#B12">12</A>), that a substantial amount of receptor<SUP> </SUP>migrated as dimer
or higher-order oligomer (data not shown). Stably<SUP> </SUP>expressed D2R</A>
produced substantially less of higher-order species<SUP> </SUP>on SDS-PAGE.
Moreover, we found that mutation to Ser of Cys-371<SUP>6.61</SUP> and
Cys-373<SUP>6.63</SUP> in the third extracellular loop, between TM6
and TM7, which leaves<SUP> </SUP>only two extracellular cysteines (the highly
conserved disulfide-bonded<SUP> </SUP>Cys-107<SUP>3.25</SUP> and
Cys-182<SUP>E2</SUP>) further decreased oligomeric SDS-resistant
species (data not<SUP> </SUP>shown). The resulting background construct
(C118<SUP>3.36</SUP>S/C371<SUP>6.61</SUP>S/C373<SUP>6.63</SUP>S) ran
almost exclusively as a heterogeneously glycosylated monomer<SUP> </SUP>of ~65
kDa on non-reducing SDS-PAGE (Fig.
<a href="#F1">1</a><I>A</I>). (As shown below,<SUP> </SUP>this
background construct, subsequently referred to as D2R</A>, was<SUP> </SUP>fully
functional and bound multiple ligands normally.) Thus, if<SUP> </SUP>the D2R</A> is
oligomeric, the oligomer dissociates in SDS. In addition,<SUP> </SUP>the D2R</A> is
not an obligatory disulfide-linked dimer in the plasma<SUP> </SUP>membrane, unlike
some class C receptors (<A HREF="#B2">2</A>, <A HREF="#B6">6</A>).



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/278/7/4385/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=174 SRC="/content/vol278/issue7/images/small/bc0733714001.gif"></A><BR>

<STRONG>View larger version</STRONG> (30K):
<BR><NOBR><A HREF="/cgi/content/full/278/7/4385/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/278/7/4385/F1"
onClick="startTarget('F1', 590, 582); this.href='/cgi/content-nw/full/278/7/4385/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Cross-linking of </B><B>D2R</B></A><B> to a homodimer by copper
phenanthroline.</B> <I>A</I>, treatment of FLAG-D2R with 0,&nbsp;10/40,
40/160, 100/400, 400/1600, and 1000/4000 &#181;<font size=-1>M</font> CuP</A>
(<I>lanes 1-6</I>, respectively). <I>B</I>, exponential
association fit of dimer/total density plotted against CuP</A> from
<I>A.&nbsp;C</I>, anti-Myc blot of anti-FLAG
immunoprecipitation of FLAG-D2R, Myc-D2R, and coexpressed FLAG-D2R and
Myc-D2R (see "Experimental Procedures"). The sharp ~130-kDa band
present in each of the extract lanes is a nonspecific band labeled by
the anti-Myc antibody. The molecular masses of protein standards are
given in kDa. Representative data from <I>n</I>&nbsp;=&nbsp;3&nbsp;experiments are shown.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->




    
    </P>

    
    <P>Using cells stably coexpressing two D2R</A> constructs, one FLAG-tagged and
the other Myc-tagged, we attempted to coimmunoprecipitate<SUP> </SUP>Myc-D2R with
an anti-FLAG monoclonal antibody and protein G.&nbsp;After<SUP> </SUP>solubilization
with DM</A> we detected no or only trace coimmunoprecipitation<SUP> </SUP>of Myc-D2R
under these conditions (Fig. <a href="#F1">1</a><I>C</I>), although the FLAG-D2R<SUP> </SUP>was
immunoprecipitated as expected (data not shown). Thus, if<SUP> </SUP>the D2R</A> is
oligomeric in the membrane, the oligomer does not survive<SUP> </SUP>DM</A><SUP> </SUP>solubilization.
    
    </P>

    
    <P>As a control before introducing engineered cysteines into FLAG-D2R for
disulfide cross-linking experiments we reacted FLAG-D2R<SUP> </SUP>in intact cells
with copper phenanthroline (CuP</A>), an oxidizing<SUP> </SUP>reagent that promotes
the formation of disulfide bonds directly<SUP> </SUP>between cysteines (<A HREF="#B25">25</A>, <A HREF="#B26">26</A>).
Reaction with CuP</A> produced a new<SUP> </SUP>band of ~133 kDa (Fig.
<a href="#F1">1</a><I>A</I>), approximately twice that of monomer.<SUP> </SUP>The
fraction of total density that was present in the ~133 kDa<SUP> </SUP>band was
plotted against increasing CuP</A> (Fig. <a href="#F1">1</a>, <I>A</I> and <I>B</I>),
giving<SUP> </SUP>half-maximal cross-linking at 60&nbsp;&#177;&nbsp;10&nbsp;&#181;<font size=-1>M</font> CuP</A>
and maximal cross-linking<SUP> </SUP>of 80&nbsp;&#177;&nbsp;14% (<I>n</I>&nbsp;=<SUP>&nbsp;</SUP>3).
    
    </P>

    
    <P>The cross-linked species size was consistent with it being a homodimer
of D2R</A>, but it was possible that it might represent<SUP> </SUP>D2R</A> cross-linked to
another protein of similar size. The partners<SUP> </SUP>in the cross-linked
species were definitively identified by coimmunoprecipitation<SUP> </SUP>of
Myc-D2R stably coexpressed with FLAG-D2R. After reaction with<SUP> </SUP>CuP</A>,
immunoprecipitation with anti-FLAG antibody produced an ~133-kDa<SUP> </SUP>band
that was recognized by anti-Myc antibody (Fig. <a href="#F1">1</a><I>C</I>). In
contrast<SUP> </SUP>when FLAG-D2R and Myc-D2R were expressed separately and then
cross-linked,<SUP> </SUP>precipitation with anti-FLAG antibody did not produce a
~133-kDa<SUP> </SUP>species recognized by anti-Myc antibody (Fig.
<a href="#F1">1</a><I>C</I>), demonstrating<SUP> </SUP>the specificity of the antibodies. These
results establish that<SUP> </SUP>the ~133-kDa band is a D2R</A> homodimer that is
disulfide cross-linked<SUP> </SUP>via one of the remaining endogenous<SUP> </SUP>cysteines.
    
    </P>

    
    <P>Mutation of Cys-168<SUP>4.58</SUP> in the fourth transmembrane segment
(TM4) to Ser (as well as to Ala or Phe, data not shown), but not
mutation<SUP> </SUP>of Cys-56<SUP>1.54</SUP>, Cys-126<SUP>3.44</SUP>, or
Cys-356<SUP>6.47</SUP>, completely prevented CuP-induced cross-linking
(Fig. <a href="#F2">2</a><I>A</I>), demonstrating<SUP> </SUP>that
this Cys at the extracellular end of TM4 forms the disulfide<SUP> </SUP>cross-link
at a symmetrical homodimer interface.



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/278/7/4385/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=58 SRC="/content/vol278/issue7/images/small/bc0733714002.gif"></A><BR>

<STRONG>View larger version</STRONG> (17K):
<BR><NOBR><A HREF="/cgi/content/full/278/7/4385/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/278/7/4385/F2"
onClick="startTarget('F2', 590, 328); this.href='/cgi/content-nw/full/278/7/4385/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Effects of mutation and ligand binding on </B><B>D2R</B></A><B>
cross-linking.</B> <I>A</I>, cross-linking of Cys mutants by
100/400 &#181;<font size=-1>M</font> CuP</A> in FLAG-D2R. <I>B</I>, treatment with
buffer (<I>lane 1</I>), 10&nbsp;&#181;<font size=-1>M</font> sulpiride (<I>lanes
2</I>&nbsp;and <I>3</I>), 1&nbsp;&#181;<font size=-1>M</font> butaclamol (<I>lanes
4</I>&nbsp;and <I>5</I>), 10&nbsp;&#181;<font size=-1>M</font> bromocriptine (<I>lane
6</I>), or 10&nbsp;&#181;<font size=-1>M</font> quinpirole (<I>lane 7</I>) for 15&nbsp;min (<I>lanes 1</I>, <I>3</I>, <I>5</I>, <I>6</I>, and
<I>7</I>) or 24&nbsp;h (<I>lanes 2</I>&nbsp;and <I>4</I>) prior
to and during cross-linking by 1000/4000 &#181;<font size=-1>M</font> CuP</A>.
Representative data from <I>n</I>&nbsp;=&nbsp;3&nbsp;experiments are
shown.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->




    
    </P>

    
    <P>To assess ligand binding effects on the dimerization state of the
receptor, we treated cells expressing the background construct<SUP> </SUP>with the
agonists, quinpirole or bromocriptine, or the antagonists,<SUP> </SUP>sulpiride or
butaclamol. Neither acute nor 24-h treatment with<SUP> </SUP>these ligands
significantly impacted cross-linking under conditions<SUP> </SUP>in which nearly
all the receptor was cross-linked (Fig. <a href="#F2">2</a><I>B</I>). This<SUP> </SUP>suggests
that the receptor is a constitutive dimer (or possibly<SUP> </SUP>a higher order
oligomer) in the plasma membrane and that ligand<SUP> </SUP>interaction does not
lead to dissociation of the<SUP> </SUP>dimer.
    
    </P>

    
    <P>To study the effects of cross-linking Cys-168<SUP>4.58</SUP> on ligand
binding, we oxidized with 1&nbsp;m<font size=-1>M</font>/4 m<font size=-1>M</font> CuP</A> to
ensure that essentially<SUP> </SUP>all D2R</A> was cross-linked (see Fig. <a href="#F1">1</a>). We
observed no change in<SUP> </SUP>the <I>K</I><SUB><I>D</I></SUB> or B<SUB>max</SUB> for
the antagonist [<SUP>3</SUP>H]<I>N</I>-methylspiperone (Fig.
<a href="#F3">3</a><I>C</I>), or in the
<I>K</I><SUB><I>I</I></SUB> for sulpiride<SUP> </SUP>or dopamine (Fig. <a href="#F3">3</a>, <I>A</I>
and <I>B</I>). We also assessed the effects of<SUP> </SUP>cross-linking
Cys-168<SUP>4.58</SUP> on dopamine-mediated inhibition of adenylyl
cyclase by the D2R</A>.<SUP> </SUP>In the absence of D2R</A>, treatment with 1&nbsp;m<font size=-1>M</font>/4 m<font size=-1>M</font> CuP</A> significantly<SUP> </SUP>inhibited
forskolin-stimulated adenylyl cyclase through a direct<SUP> </SUP>effect on
adenylyl cyclase (data not shown). This resulted in<SUP> </SUP>an apparent
decrease in the potency and efficacy of dopamine in<SUP> </SUP>both the
Cys-168<SUP>4.58</SUP> and C168<SUP>4.58</SUP>S constructs
after treatment with CuP</A> (Fig. <a href="#F3">3</a><I>D</I>). Nonetheless,<SUP> </SUP>after
treatment with CuP</A>, dopamine was equally efficacious at<SUP> </SUP>inhibiting
cyclase in a Cys-168<SUP>4.58</SUP> construct that was highly
cross-linked and in a C168<SUP>4.58</SUP>S construct that did not
cross-link. We observed no dopamine-mediated<SUP> </SUP>inhibition of cAMP levels
in untransfected EM4 cells. This argues<SUP> </SUP>that the dopamine-mediated
inhibition of cyclase occurred only<SUP> </SUP>via the stably expressed
D2R</A>.



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/278/7/4385/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=174 SRC="/content/vol278/issue7/images/small/bc0733714003.gif"></A><BR>

<STRONG>View larger version</STRONG> (36K):
<BR><NOBR><A HREF="/cgi/content/full/278/7/4385/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/278/7/4385/F3"
onClick="startTarget('F3', 590, 582); this.href='/cgi/content-nw/full/278/7/4385/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Effects of cross-linking on ligand binding
and activation of the </B><B>D2R</B></A>. In <I>A-D</I>, treatment with
1000/4000 &#181;<font size=-1>M</font> CuP</A> is shown in <I>solid symbols</I> or
<I>filled bars</I>, whereas control treatment is shown in
<I>open symbols</I> or <I>bars. A</I> and
<I>B</I>, competition of
[<SUP>3</SUP>H]<I>N</I>-methylspiperone binding by sulpiride
(<I>squares</I>) or dopamine (<I>circles</I>) in the FLAG-D2R
(<I>A</I>) (<I>K</I><SUB><I>I</I></SUB>&nbsp;=&nbsp;2.0&nbsp;&#177;&nbsp;0.2&nbsp;n<font size=-1>M</font>
and 2.4&nbsp;&#177;&nbsp;0.4&nbsp;n<font size=-1>M</font> for sulpiride and 2.7&nbsp;&#177;&nbsp;0.4&nbsp;&#181;<font size=-1>M</font> and 2.0&nbsp;&#177;&nbsp;0.3&nbsp;&#181;<font size=-1>M</font> for dopamine
without and with CuP</A>, respectively (mean and S.E., <I>n</I>&nbsp;=&nbsp;3)) or FLAG-D2R-C168<SUP>4.58</SUP>S (<I>B</I>)
(<I>K</I><SUB><I>I</I></SUB>&nbsp;=&nbsp;1.4&nbsp;&#177;&nbsp;0.2&nbsp;&#181;<font size=-1>M</font> and 1.8&nbsp;&#177;&nbsp;0.3&nbsp;&#181;<font size=-1>M</font> for sulpiride and 2.0&nbsp;&#177;&nbsp;0.4&nbsp;&#181;<font size=-1>M</font> and 2.2&nbsp;&#177;&nbsp;0.3&nbsp;&#181;<font size=-1>M</font> for dopamine
without and with CuP</A>, respectively (mean and S.E., <I>n</I>&nbsp;=&nbsp;3)). <I>C</I>, [<SUP>3</SUP>H]<I>N</I>-methylspiperone
saturation to FLAG-D2R (<I>squares</I>) (<I>K</I><SUB><I>D</I></SUB>&nbsp;=&nbsp;88&nbsp;&#177;&nbsp;12&nbsp;p<font size=-1>M</font> and 84&nbsp;&#177;&nbsp;6&nbsp;p<font size=-1>M</font> and
B<SUB>max</SUB>&nbsp;=&nbsp;7.6&nbsp;&#177;&nbsp;0.3&nbsp;pmol/mg protein and 7.2&nbsp;&#177;&nbsp;0.3&nbsp;pmol/mg protein without and with CuP</A>, respectively (mean and S.E.,
<I>n</I>&nbsp;=&nbsp;3)) or FLAG-D2R-C168<SUP>4.58</SUP>S
(<I>circles</I>) (<I>K</I><SUB><I>D</I></SUB>&nbsp;=&nbsp;74&nbsp;&#177;&nbsp;5&nbsp;p<font size=-1>M</font> and 75&nbsp;&#177;&nbsp;2&nbsp;p<font size=-1>M</font> and B<SUB>max</SUB>&nbsp;=&nbsp;5.7&nbsp;&#177;&nbsp;0.4&nbsp;pmol/mg protein and 6.1&nbsp;&#177;&nbsp;0.8&nbsp;pmol/mg protein
without and with CuP</A>, respectively (mean and S.E., <I>n</I>&nbsp;=&nbsp;3)). <I>D</I>, inhibition of forskolin-stimulated cAMP accumulation
by 1&nbsp;&#181;<font size=-1>M</font> dopamine in FLAG-D2R and
FLAG-D2R-C168<SUP>4.58</SUP>S (mean and S.E., <I>n</I>&nbsp;=&nbsp;3).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->




    
    </P>

    
    <P>Because cross-linking requires that only one of the two cysteines
involved is modified initially by the reagent, and the derivatized<SUP> </SUP>cysteine then reacts by collision with the second unmodified cysteine,<SUP> </SUP>the rate of collision must be much faster than the rate of initial<SUP> </SUP>modification. This is consistent with the cysteines being very<SUP> </SUP>close
initially. The very high fraction of receptor that can be<SUP> </SUP>cross-linked,
the apparent specificity of the cross-linking, based<SUP> </SUP>on the appearance
of a single homodimer band, and the lack of<SUP> </SUP>cross-linking of
Cys-56<SUP>1.54</SUP>, which based on the bovine rhodopsin structure
has a similar<SUP> </SUP>lipid accessibility as Cys-168<SUP>4.58</SUP>, all argue
for the proximity of the TM4 cysteines in the native<SUP> </SUP>state. Thus, it is
likely that in the membrane, untreated with<SUP> </SUP>CuP</A>, D2R</A> exists as a
homodimer but that this dimer does not survive<SUP> </SUP>detergent<SUP> </SUP>solubilization.
    
    </P>

    
    <P>Cross-linking does not impair the ability of dopamine to inhibit
cyclase via the D2R</A> (Fig. <a href="#F3">3</a>), demonstrating that the receptor<SUP> </SUP>can bind
dopamine and activate G<SUB>i</SUB> with a disulfide between
Cys-168<SUP>4.58</SUP> in each "subunit" of the dimer. Thus,
significant movement of<SUP> </SUP>the dimer interface at the
Cys-168<SUP>4.58</SUP> position is not necessary for function.
Moreover, ligand recognition<SUP> </SUP>was unaltered by cross-linking, and the
extent of cross-linking<SUP> </SUP>was unaltered by treatment with agonists or
antagonists, suggesting<SUP> </SUP>that the receptor is a constitutive dimer.
These results are consistent<SUP> </SUP>with the recent findings of Mercier
<I>et al.</I> (<A HREF="#B27">27</A>). Using quantitative<SUP> </SUP>bioluminescence resonance
energy transfer (BRET</A>), they showed<SUP> </SUP>that more than 82% of
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>2</SUB>-adrenergic receptor in the plasma membrane<SUP> </SUP>exists as a
constitutive dimer (or higher order oligomer) over<SUP> </SUP>a broad range of
expression levels. They also failed to observe<SUP> </SUP>a change in BRET</A> upon
addition of ligand and suggested that the<SUP> </SUP>dimer does not form or
dissociate upon<SUP> </SUP>activation.
    
    </P>

    
    <P>Bovine rhodopsin was crystallized in detergent as a non-physiological
dimer in which the cytoplasmic face of one molecule<SUP> </SUP>is in the same
plane as the extracellular face of the second molecule<SUP> </SUP>(<A HREF="#B28">28</A>). It is
possible, however, that the native oligomeric structure<SUP> </SUP>of rhodopsin is
disrupted in detergent and is therefore not seen<SUP> </SUP>in the crystal
structure. Indeed, our findings that the dopamine<SUP> </SUP>receptor is a dimer
in the plasma membrane but cannot be immunoprecipitated<SUP> </SUP>from a DM</A>
extract argues that the D2 receptor native quaternary<SUP> </SUP>structure is not
preserved in this detergent. Interestingly, squid<SUP> </SUP>rhodopsin in
detergent forms two-dimensional crystals that show<SUP> </SUP>a TM4 dimer
interface (<A HREF="#B29">29</A>) (Fig. <a href="#F4">4</a><I>A</I>).
These results suggest<SUP> </SUP>that the TM4 dimer interface may be common to
other GPCRs as well<SUP> </SUP>as the D2R</A>.



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/278/7/4385/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=134 HEIGHT=200 SRC="/content/vol278/issue7/images/small/bc0733714004.gif"></A><BR>

<STRONG>View larger version</STRONG> (97K):
<BR><NOBR><A HREF="/cgi/content/full/278/7/4385/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/278/7/4385/F4"
onClick="startTarget('F4', 444, 640); this.href='/cgi/content-nw/full/278/7/4385/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>The TM4 homodimer interface.</B>
<I>A</I>, an extracellular view of the squid rhodopsin
projection structure, modified from Ref. <A HREF="#B29">29</A>. The TMs from two molecules
are numbered, with one dimer subunit shaded <I>green</I>. The
position of retinal within the binding site crevice is indicated by
<I>R</I>. The TM4 dimer interface is indicated by <I>arcs.
B</I>, three-dimensional molecular representation of the
transmembrane domain, viewed extracellularly in the orientation of the
<I>green</I> dimer subunit from <I>A</I>, showing the C<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">
ribbon of the high resolution structure of bovine rhodopsin with the
aligned accessible and protected positions in the D2 receptor shown in
<I>yellow</I> and accessible but not protected positions shown in
<I>orange</I>. The D2R</A> side chains from TM4 that were accessible
and protected by ligand but face outward in rhodopsin are shown in
<I>purple</I>, and the cross-linked Cys-168<SUP>4.58</SUP> side
chain is shown in <I>white</I>.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->




    
    </P>

    
    <P>Using the substituted cysteine accessibility method in the D2R</A>, we
found that cysteines in TM4 substituted for the highly<SUP> </SUP>conserved
Trp-160<SUP>4.50</SUP> as well as for Phe-164<SUP>4.54</SUP> and
Leu-171<SUP>4.61</SUP> were accessible to charged sulfhydryl reagents
and that this<SUP> </SUP>reaction was protected by the antagonist sulpiride (<A HREF="#B30">30</A>).
We<SUP> </SUP>originally inferred that these residues in TM4 faced the binding<SUP> </SUP>site crevice. Surprisingly, in the bovine rhodopsin structure,<SUP> </SUP>the
aligned residues Trp-161<SUP>4.50</SUP>, Leu-165<SUP>4.54</SUP>, and
Leu-172<SUP>4.61</SUP> face outward and not into the binding site
crevice (<A HREF="#B28">28</A>). Our<SUP> </SUP>observations regarding the anomalous conservation and
accessibility<SUP> </SUP>of this "back face" of TM4 suggested to us the
possibility that<SUP> </SUP>this surface might be at the interface between two D2R</A>
subunits<SUP> </SUP>(<A HREF="#B31">31</A>). Our finding that the site of cross-linking in D2R</A> is
Cys-168<SUP>4.58</SUP> at the extracellular end of TM4 directly
adjacent to these accessible<SUP> </SUP>residues (Fig. <a href="#F4">4</a><I>B</I>) is
consistent with this hypothesis that TM4<SUP> </SUP>forms a symmetrical dimer
interface. We are currently extending<SUP> </SUP>these studies to include other
residues in TM4 in an attempt to<SUP> </SUP>map the entire interface and to assess
whether conformational<SUP> </SUP>changes occur at this interface in different
functional states<SUP> </SUP>of the receptor. Given that cysteines substituted for
Trp-160<SUP>4.50</SUP>, Phe-164<SUP>4.54</SUP>, and
Leu-171<SUP>4.61</SUP> were protected from reaction by sulpiride, we
think it likely<SUP> </SUP>that such conformational changes do occur and may
mediate cross-talk<SUP> </SUP>between receptor<SUP> </SUP>subunits.
    
    


<BR><BR CLEAR=ALL>

</TXT>




<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We thank Myles Akabas, Juan A.&nbsp;Ballesteros,
Marta Filizola, Arthur Karlin, and Harel Weinstein for helpful
discussion and<SUP> </SUP>Gebhard F.&nbsp;X.&nbsp;Schertler and Helen R.&nbsp;Saibil for
providing the<SUP> </SUP>photograph used to create Fig. <a href="#F4">4</a><I>A</I>.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was supported in part by National Institutes of
Health Grants MH57324 and MH54137 and by the Lebovitz Trust.The<SUP> </SUP>costs of publication of this
article were defrayed in part by<SUP> </SUP>the
payment of page charges. The article
must therefore be hereby<SUP> </SUP>marked
"<I>advertisement</I>" in
accordance with 18&nbsp;U.S.C. Section
1734<SUP>&nbsp;</SUP>solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN154"><SUP>&#182;</SUP></A>
To whom correspondence should be addressed: Center for
Molecular Recognition, Columbia University, P&nbsp;&amp;&nbsp;S 11-401,&nbsp;630&nbsp;West<SUP> </SUP>168<SUP>th</SUP> St., Box 7,&nbsp;New York, NY 10032.&nbsp;Tel.: 212-305-7308;
Fax: 212-305-5594;<SUP> </SUP>E-mail: jaj2@columbia.edu.

<P>


<P>
Published, JBC Papers in Press, December 19,&nbsp;2002,&nbsp;DOI 10.1074/jbc.C200679200

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

GPCR, G-protein-coupled receptor;

TM, transmembrane segment;

D2R, dopamine D2
receptor;

PBS, phosphate-buffered saline;

NEM, <I>N</I>-ethylmaleimide;

DM, dodecyl maltoside;

BRET, bioluminescence resonance energy transfer;

CuP, copper
phenanthroline.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS AND DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Gether, U.



(2000)

<I>Endocr. Rev.</I>
<B>21</B>,
90-113<!-- HIGHWIRE ID="278:7:4385:1" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=edrv&resid=21/1/90" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Bai, M.,
Trivedi, S.,
 and Brown, E. M.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
23605-23610<!-- HIGHWIRE ID="278:7:4385:2" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/36/23605" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

White, J. H.,
Wise, A.,
Main, M. J.,
Green, A.,
Fraser, N. J.,
Disney, G. H.,
Barnes, A. A.,
Emson, P.,
Foord, S. M.,
 and Marshall, F. H.



(1998)

<I>Nature</I>
<B>396</B>,
679-682<!-- HIGHWIRE ID="278:7:4385:3" --><A HREF="/cgi/external_ref?access_num=10.1038/25354&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9872316&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9872316&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Jones, K. A.,
Borowsky, B.,
Tamm, J. A.,
Craig, D. A.,
Durkin, M. M.,
Dai, M.,
Yao, W. J.,
Johnson, M.,
Gunwaldsen, C.,
Huang, L. Y.,
Tang, C.,
Shen, Q.,
Salon, J. A.,
Morse, K.,
Laz, T.,
Smith, K. E.,
Nagarathnam, D.,
Noble, S. A.,
Branchek, T. A.,
 and Gerald, C.



(1998)

<I>Nature</I>
<B>396</B>,
674-679<!-- HIGHWIRE ID="278:7:4385:4" --><A HREF="/cgi/external_ref?access_num=10.1038/25348&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9872315&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9872315&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Kaupmann, K.,
Malitschek, B.,
Schuler, V.,
Heid, J.,
Froestl, W.,
Beck, P.,
Mosbacher, J.,
Bischoff, S.,
Kulik, A.,
Shigemoto, R.,
Karschin, A.,
 and Bettler, B.



(1998)

<I>Nature</I>
<B>396</B>,
683-687<!-- HIGHWIRE ID="278:7:4385:5" --><A HREF="/cgi/external_ref?access_num=10.1038/25360&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9872317&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9872317&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Romano, C.,
Yang, W. L.,
 and O'Malley, K. L.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
28612-28616<!-- HIGHWIRE ID="278:7:4385:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/45/28612" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Margeta-Mitrovic, M.,
Jan, Y. N.,
 and Jan, L. Y.



(2000)

<I>Neuron</I>
<B>27</B>,
97-106<!-- HIGHWIRE ID="278:7:4385:7" --><A HREF="/cgi/external_ref?access_num=10939334&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10939334&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Havlickova, M.,
Prezeau, L.,
Duthey, B.,
Bettler, B.,
Pin, J. P.,
 and Blahos, J.



(2002)

<I>Mol. Pharmacol.</I>
<B>62</B>,
343-350<!-- HIGHWIRE ID="278:7:4385:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=molpharm&resid=62/2/343" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Duthey, B.,
Caudron, S.,
Perroy, J.,
Bettler, B.,
Fagni, L.,
Pin, J. P.,
 and Prezeau, L.



(2002)

<I>J. Biol. Chem.</I>
<B>277</B>,
3236-3241<!-- HIGHWIRE ID="278:7:4385:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=277/5/3236" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Armstrong, D.,
 and Strange, P. G.



(2001)

<I>J. Biol. Chem.</I>
<B>276</B>,
22621-22629<!-- HIGHWIRE ID="278:7:4385:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=276/25/22621" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Lee, S. P.,
O'Dowd, B. F., Ng, G.&nbsp;Y.,
Varghese, G.,
Akil, H.,
Mansour, A.,
Nguyen, T.,
 and George, S. R.



(2000)

<I>Mol. Pharmacol.</I>
<B>58</B>,
120-128<!-- HIGHWIRE ID="278:7:4385:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=molpharm&resid=58/1/120" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Ng, G. Y.,
O'Dowd, B. F.,
Lee, S. P.,
Chung, H. T.,
Brann, M. R.,
Seeman, P.,
 and George, S. R.



(1996)

<I>Biochem. Biophys. Res. Commun.</I>
<B>227</B>,
200-204<!-- HIGHWIRE ID="278:7:4385:12" --><A HREF="/cgi/external_ref?access_num=10.1006/bbrc.1996.1489&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8858125&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8858125&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Zawarynski, P.,
Tallerico, T.,
Seeman, P.,
Lee, S. P.,
O'Dowd, B. F.,
 and George, S. R.



(1998)

<I>FEBS Lett.</I>
<B>441</B>,
383-386<!-- HIGHWIRE ID="278:7:4385:13" --><A HREF="/cgi/external_ref?access_num=10.1016/S0014-5793(98)01588-9&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9891976&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9891976&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Rios, C. D.,
Jordan, B. A.,
Gomes, I.,
 and Devi, L. A.



(2001)

<I>Pharmacol. Ther.</I>
<B>92</B>,
71-87<!-- HIGHWIRE ID="278:7:4385:14" --><A HREF="/cgi/external_ref?access_num=10.1016/S0163-7258(01)00160-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11916530&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11916530&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

George, S. R.,
O'Dowd, B. F.,
 and Lee, S. P.



(2002)

<I>Nat. Rev. Drug Discov.</I>
<B>1</B>,
808-820<!-- HIGHWIRE ID="278:7:4385:15" --><A HREF="/cgi/external_ref?access_num=10.1038/nrd913&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=12360258&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=12360258&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Angers, S.,
Salahpour, A.,
 and Bouvier, M.



(2002)

<I>Annu. Rev. Pharmacol. Toxicol.</I>
<B>42</B>,
409-435<!-- HIGHWIRE ID="278:7:4385:16" --><A HREF="/cgi/external_ref?access_num=10.1146/annurev.pharmtox.42.091701.082314&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11807178&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11807178&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Gouldson, P. R.,
Higgs, C.,
Smith, R. E.,
Dean, M. K.,
Gkoutos, G. V.,
 and Reynolds, C. A.



(2000)

<I>Neuropsychopharmacology</I>
<B>23</B>,
S60-S77<!-- HIGHWIRE ID="278:7:4385:17" --><A HREF="/cgi/external_ref?access_num=10.1016/S0893-133X(00)00153-6&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11008068&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11008068&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Gouldson, P. R.,
Snell, C. R.,
Bywater, R. P.,
Higgs, C.,
 and Reynolds, C. A.



(1998)

<I>Protein Eng.</I>
<B>11</B>,
1181-1193<!-- HIGHWIRE ID="278:7:4385:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=proeng&resid=11/12/1181" >[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Schulz, A.,
Grosse, R.,
Schultz, G.,
Gudermann, T.,
 and Schoneberg, T.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
2381-2389<!-- HIGHWIRE ID="278:7:4385:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/4/2381" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Hamdan, F. F.,
Ward, S. D.,
Siddiqui, N. A.,
Bloodworth, L. M.,
 and Wess, J.



(2002)

<I>Biochemistry</I>
<B>41</B>,
7647-7658<!-- HIGHWIRE ID="278:7:4385:20" --><A HREF="/cgi/external_ref?access_num=10.1021/bi016029c&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=12056896&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=12056896&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Hebert, T. E.,
Moffett, S.,
Morello, J. P.,
Loisel, T. P.,
Bichet, D. G.,
Barret, C.,
 and Bouvier, M.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
16384-16392<!-- HIGHWIRE ID="278:7:4385:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/27/16384" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Gouldson, P. R.,
Dean, M. K.,
Snell, C. R.,
Bywater, R. P.,
Gkoutos, G.,
 and Reynolds, C. A.



(2001)

<I>Protein Eng.</I>
<B>14</B>,
759-767<!-- HIGHWIRE ID="278:7:4385:22" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=proeng&resid=14/10/759" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>Filizola, M., Olmea, O., and Weinstein, H.&nbsp;(2002) <I>Protein
Eng.</I> <B>15,&nbsp;</B>in press


<!-- HIGHWIRE ID="278:7:4385:23" --><!-- /HIGHWIRE -->

    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Filizola, M.,
 and Weinstein, H.



(2002)

<I>Biopolymers (Peptide Science</I>)<I></I>
<B>66</B>,
317-325<!-- HIGHWIRE ID="278:7:4385:24" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Careaga, C. L.,
 and Falke, J. J.



(1992)

<I>J. Mol. Biol.</I>
<B>226</B>,
1219-1235<!-- HIGHWIRE ID="278:7:4385:25" --><A HREF="/cgi/external_ref?access_num=1518053&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1518053&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Wu, J.,
 and Kaback, H. R.



(1996)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>93</B>,
14498-14502<!-- HIGHWIRE ID="278:7:4385:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=93/25/14498" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Mercier, J. F.,
Salahpour, A.,
Angers, S.,
Breit, A.,
 and Bouvier, M.



(2002)

<I>J. Biol. Chem.</I>
<B>277</B>,
44925-44931<!-- HIGHWIRE ID="278:7:4385:27" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=277/47/44925" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Palczewski, K.,
Kumasaka, T.,
Hori, T.,
Behnke, C. A.,
Motoshima, H.,
Fox, B. A., Le,
Trong, I.,
Teller, D. C.,
Okada, T.,
Stenkamp, R. E.,
Yamamoto, M.,
 and Miyano, M.



(2000)

<I>Science</I>
<B>289</B>,
739-745<!-- HIGHWIRE ID="278:7:4385:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=289/5480/739" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Davies, A.,
Gowen, B. E.,
Krebs, A. M.,
Schertler, G. F.,
 and Saibil, H. R.



(2001)

<I>J. Mol. Biol.</I>
<B>314</B>,
455-463<!-- HIGHWIRE ID="278:7:4385:29" --><A HREF="/cgi/external_ref?access_num=10.1006/jmbi.2001.5167&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11846559&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11846559&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Javitch, J. A.,
Shi, L.,
Simpson, M. M.,
Chen, J.,
Chiappa, V.,
Visiers, I.,
Weinstein, H.,
 and Ballesteros, J. A.



(2000)

<I>Biochemistry</I>
<B>39</B>,
12190-12199<!-- HIGHWIRE ID="278:7:4385:30" --><A HREF="/cgi/external_ref?access_num=10.1021/bi001069m&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11015197&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11015197&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Ballesteros, J. A.,
Shi, L.,
 and Javitch, J. A.



(2001)

<I>Mol. Pharmacol.</I>
<B>60</B>,
1-19<!-- HIGHWIRE ID="278:7:4385:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=molpharm&resid=60/1/1" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Visiers, I.,
Ballesteros, J. A.,
 and Weinstein, H.



(2002)

<I>Methods Enzymol.</I>
<B>343</B>,
329-371<!-- HIGHWIRE ID="278:7:4385:32" --><A HREF="/cgi/external_ref?access_num=11665578&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=11665578&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Saunders, C.,
Ferrer, J. V.,
Shi, L.,
Chen, J.,
Merrill, G.,
Lamb, M. E.,
Leeb-Lundberg, L. M.,
Carvelli, L.,
Javitch, J. A.,
 and Galli, A.



(2000)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>97</B>,
6850-6855<!-- HIGHWIRE ID="278:7:4385:33" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=97/12/6850" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Robbins, A. K.,
 and Horlick, R. A.



(1998)

<I>BioTechniques</I>
<B>25</B>,
240-244<!-- HIGHWIRE ID="278:7:4385:34" --><A HREF="/cgi/external_ref?access_num=9714883&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9714883&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Hastrup, H.,
Karlin, A.,
 and Javitch, J. A.



(2001)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>98</B>,
10055-10060<!-- HIGHWIRE ID="278:7:4385:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=98/18/10055" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Laemmli, U. K.



(1970)

<I>Nature</I>
<B>227</B>,
680-685<!-- HIGHWIRE ID="278:7:4385:36" --><A HREF="/cgi/external_ref?access_num=5432063&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=5432063&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Liapakis, G.,
Ballesteros, J. A.,
Papachristou, S.,
Chan, W. C.,
Chen, X.,
 and Javitch, J. A.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
37779-37788<!-- HIGHWIRE ID="278:7:4385:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/48/37779" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2003 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	
	



 




<BR CLEAR=ALL>



  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>



<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://molpharm.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Mol Pharmacol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/molpharm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	D. S. Kang, C. Gustafsson, M. Morgelin, and L. M. F. Leeb-Lundberg<BR>
	<STRONG>B1 Bradykinin Receptor Homo-Oligomers in Receptor Cell Surface Expression and Signaling: Effects of Receptor Fragments</STRONG><BR>
	
		
			Mol. Pharmacol.,
		
	
        
        January&nbsp;1,&nbsp;2005;
	67(1):
	309 - 318.
<BR>
<A HREF="http://www.molpharm.org/cgi/content/abstract/67/1/309">[Abstract]</A>

<A HREF="http://www.molpharm.org/cgi/content/full/67/1/309">[Full Text]</A>
<A HREF="http://www.molpharm.org/cgi/reprint/67/1/309">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://molpharm.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Mol Pharmacol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/molpharm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. J. Carrillo, J. F. Lopez-Gimenez, and G. Milligan<BR>
	<STRONG>Multiple Interactions between Transmembrane Helices Generate the Oligomeric {alpha}1b-Adrenoceptor</STRONG><BR>
	
		
			Mol. Pharmacol.,
		
	
        
        November&nbsp;1,&nbsp;2004;
	66(5):
	1123 - 1137.
<BR>
<A HREF="http://www.molpharm.org/cgi/content/abstract/66/5/1123">[Abstract]</A>

<A HREF="http://www.molpharm.org/cgi/content/full/66/5/1123">[Full Text]</A>
<A HREF="http://www.molpharm.org/cgi/reprint/66/5/1123">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jpet.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jpet.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jpet.aspetjournals.org"><IMG ALT="J. Pharmacol. Exp. Ther." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jpet.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. A. Bakker, G. Dees, J. J. Carrillo, R. G. Booth, J. F. Lopez-Gimenez, G. Milligan, P. G. Strange, and R. Leurs<BR>
	<STRONG>Domain Swapping in the Human Histamine H1 Receptor</STRONG><BR>
	
		
			J. Pharmacol. Exp. Ther.,
		
	
        
        October&nbsp;1,&nbsp;2004;
	311(1):
	131 - 138.
<BR>
<A HREF="http://www.jpet.org/cgi/content/abstract/311/1/131">[Abstract]</A>

<A HREF="http://www.jpet.org/cgi/content/full/311/1/131">[Full Text]</A>
<A HREF="http://www.jpet.org/cgi/reprint/311/1/131">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://molpharm.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Mol Pharmacol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/molpharm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan<BR>
	<STRONG>High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor</STRONG><BR>
	
		
			Mol. Pharmacol.,
		
	
        
        August&nbsp;1,&nbsp;2004;
	66(2):
	228 - 239.
<BR>
<A HREF="http://www.molpharm.org/cgi/content/abstract/66/2/228">[Abstract]</A>

<A HREF="http://www.molpharm.org/cgi/content/full/66/2/228">[Full Text]</A>
<A HREF="http://www.molpharm.org/cgi/reprint/66/2/228">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Breit, M. Lagace, and M. Bouvier<BR>
	<STRONG>Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;2,&nbsp;2004;
	279(27):
	28756 - 28765.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/279/27/28756">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/279/27/28756">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/279/27/28756">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://molpharm.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Mol Pharmacol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/molpharm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. Milligan<BR>
	<STRONG>G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology</STRONG><BR>
	
		
			Mol. Pharmacol.,
		
	
        
        July&nbsp;1,&nbsp;2004;
	66(1):
	1 - 7.
<BR>
<A HREF="http://www.molpharm.org/cgi/content/abstract/66/1/1">[Abstract]</A>

<A HREF="http://www.molpharm.org/cgi/content/full/66/1/1">[Full Text]</A>
<A HREF="http://www.molpharm.org/cgi/reprint/66/1/1">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://edrv.endojournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://edrv.endojournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://edrv.endojournals.org"><IMG ALT="Endocr Rev" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/edrv.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley<BR>
	<STRONG>Gonadotropin-Releasing Hormone Receptors</STRONG><BR>
	
		
			Endocr. Rev.,
		
	
        
        April&nbsp;1,&nbsp;2004;
	25(2):
	235 - 275.
<BR>
<A HREF="http://edrv.endojournals.org/cgi/content/abstract/25/2/235">[Abstract]</A>

<A HREF="http://edrv.endojournals.org/cgi/content/full/25/2/235">[Full Text]</A>
<A HREF="http://edrv.endojournals.org/cgi/reprint/25/2/235">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	C. Hague, M. A. Uberti, Z. Chen, R. A. Hall, and K. P. Minneman<BR>
	<STRONG>Cell Surface Expression of {alpha}1D-Adrenergic Receptors Is Controlled by Heterodimerization with {alpha}1B-Adrenergic Receptors</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;9,&nbsp;2004;
	279(15):
	15541 - 15549.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/279/15/15541">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/279/15/15541">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/279/15/15541">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. J. Baucum II, K. S. Rau, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein<BR>
	<STRONG>Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        March&nbsp;31,&nbsp;2004;
	24(13):
	3436 - 3443.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/24/13/3436">[Abstract]</A>

<A HREF="http://www.jneurosci.org/cgi/content/full/24/13/3436">[Full Text]</A>
<A HREF="http://www.jneurosci.org/cgi/reprint/24/13/3436">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y.-X. Tao, N. B. Johnson, and D. L. Segaloff<BR>
	<STRONG>Constitutive and Agonist-dependent Self-association of the Cell Surface Human Lutropin Receptor</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        February&nbsp;13,&nbsp;2004;
	279(7):
	5904 - 5914.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/279/7/5904">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/279/7/5904">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/279/7/5904">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org"><IMG ALT="Proc. Natl. Acad. Sci. U. S. A." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Shi and J. A. Javitch<BR>
	<STRONG>The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice</STRONG><BR>
	
		
			PNAS,
		
	
        
        January&nbsp;13,&nbsp;2004;
	101(2):
	440 - 445.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/101/2/440">[Abstract]</A>

<A HREF="http://www.pnas.org/cgi/content/full/101/2/440">[Full Text]</A>
<A HREF="http://www.pnas.org/cgi/reprint/101/2/440">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://emboreports.npgjournals.com"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboreports.npgjournals.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://emboreports.npgjournals.com"><IMG ALT="EMBO Reports" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emborep.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Terrillon and M. Bouvier<BR>
	<STRONG>Roles of G-protein-coupled receptor dimerization: From ontogeny to signalling regulation</STRONG><BR>
	
		
			EMBO Rep.,
		
	
        
        January&nbsp;1,&nbsp;2004;
	5(1):
	30 - 34.
<BR>
<A HREF="http://emboreports.npgjournals.com/cgi/content/abstract/5/1/30">[Abstract]</A>

<A HREF="http://emboreports.npgjournals.com/cgi/content/full/5/1/30">[Full Text]</A>
<A HREF="http://emboreports.npgjournals.com/cgi/reprint/5/1/30">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://circres.ahajournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://circres.ahajournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://circres.ahajournals.org"><IMG ALT="Circulation Research" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/circresaha.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. E. Breitwieser<BR>
	<STRONG>G Protein-Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling</STRONG><BR>
	
		
			Circ. Res.,
		
	
        
        January&nbsp;9,&nbsp;2004;
	94(1):
	17 - 27.
<BR>
<A HREF="http://www.circresaha.org/cgi/content/abstract/94/1/17">[Abstract]</A>

<A HREF="http://www.circresaha.org/cgi/content/full/94/1/17">[Full Text]</A>
<A HREF="http://www.circresaha.org/cgi/reprint/94/1/17">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. C. Overton, S. L. Chinault, and K. J. Blumer<BR>
	<STRONG>Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;5,&nbsp;2003;
	278(49):
	49369 - 49377.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/49/49369">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/49/49369">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/49/49369">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.biolreprod.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.biolreprod.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.biolreprod.org"><IMG ALT="Biol Reprod" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/biolreprod.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	D. A. Roess and S. M.L. Smith<BR>
	<STRONG>Self-Association and Raft Localization of Functional Luteinizing Hormone Receptors</STRONG><BR>
	
		
			Biol Reprod,
		
	
        
        December&nbsp;1,&nbsp;2003;
	69(6):
	1765 - 1770.
<BR>
<A HREF="http://www.biolreprod.org/cgi/content/abstract/69/6/1765">[Abstract]</A>

<A HREF="http://www.biolreprod.org/cgi/content/full/69/6/1765">[Full Text]</A>
<A HREF="http://www.biolreprod.org/cgi/reprint/69/6/1765">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S. R. Goldberg, K. Neve, K. Fuxe, L. F. Agnati, A. S. Woods, S. Ferre, C. Lluis, M. Bouvier, and R. Franco<BR>
	<STRONG>Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization: QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;21,&nbsp;2003;
	278(47):
	46741 - 46749.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/47/46741">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/47/46741">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/47/46741">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. J. Carrillo, J. Pediani, and G. Milligan<BR>
	<STRONG>Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;24,&nbsp;2003;
	278(43):
	42578 - 42587.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/43/42578">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/43/42578">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/43/42578">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	F. Trettel, S. Di Bartolomeo, C. Lauro, M. Catalano, M. T. Ciotti, and C. Limatola<BR>
	<STRONG>Ligand-independent CXCR2 Dimerization</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;17,&nbsp;2003;
	278(42):
	40980 - 40988.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/42/40980">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/42/40980">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/42/40980">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Stanasila, J.-B. Perez, H. Vogel, and S. Cotecchia<BR>
	<STRONG>Oligomerization of the {alpha}1a- and {alpha}1b-Adrenergic Receptor Subtypes: POTENTIAL IMPLICATIONS IN RECEPTOR INTERNALIZATION</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;10,&nbsp;2003;
	278(41):
	40239 - 40251.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/41/40239">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/41/40239">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/41/40239">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.ejbiochem.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.ejbiochem.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.ejbiochem.org"><IMG ALT="Eur J Biochem" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ejbiochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Gazi, J. F. Lopez-Gimenez, M. P. Rudiger, and P. G. Strange<BR>
	<STRONG>Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9 ) and in HEK293 cells: Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer</STRONG><BR>
	
		
			Eur. J. Biochem.,
		
	
        
        October&nbsp;1,&nbsp;2003;
	270(19):
	3928 - 3938.
<BR>
<A HREF="http://www.ejbiochem.org/cgi/content/abstract/270/19/3928">[Abstract]</A>

<A HREF="http://www.ejbiochem.org/cgi/content/full/270/19/3928">[Full Text]</A>
<A HREF="http://www.ejbiochem.org/cgi/reprint/270/19/3928">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	D. H. Floyd, A. Geva, S. P. Bruinsma, M. C. Overton, K. J. Blumer, and T. J. Baranski<BR>
	<STRONG>C5a Receptor Oligomerization: II. FLUORESCENCE RESONANCE ENERGY  TRANSFER STUDIES OF A HUMAN G PROTEIN-COUPLED RECEPTOR EXPRESSED IN  YEAST</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        September&nbsp;12,&nbsp;2003;
	278(37):
	35354 - 35361.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/37/35354">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/37/35354">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/37/35354">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. M. Klco, T. B. Lassere, and T. J. Baranski<BR>
	<STRONG>C5a Receptor Oligomerization: I. DISULFIDE TRAPPING REVEALS OLIGOMERS  AND POTENTIAL CONTACT SURFACES IN A G PROTEIN-COUPLED  RECEPTOR</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        September&nbsp;12,&nbsp;2003;
	278(37):
	35345 - 35353.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/37/35345">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/37/35345">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/37/35345">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>
 
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Liang, D. Fotiadis, S. Filipek, D. A. Saperstein, K. Palczewski, and A. Engel<BR>
	<STRONG>Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        June&nbsp;13,&nbsp;2003;
	278(24):
	21655 - 21662.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/24/21655">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/24/21655">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/24/21655">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
 </TABLE>

	











<BR CLEAR=ALL>


	
	 
		
		  
			
	
		<table class="content_box_outer_table"
		 
			
				
					
						align="right"
					
				
			
		>
			<tr>
			<td>
	

<!-- beginning of inner table -->
	<table class="content_box_inner_table">
<!-- citation -->

	
		




	

	

	
		
			
<tr><td class="content_box_title_highlight" colspan="2">This Article</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				
				<strong><a href="/cgi/content/abstract/278/7/4385">
				Abstract</a></strong>
				 					<img alt="" width="32" height="7" border="0" src="/icons/shared/toc/free.gif">
				
	
				</td></tr>
			
		
		
	

	
	
	

	
	
	


	
	
	

	
	
	

	
	
	

	
	
	

	
		
	

	

	
		
			
		
	

	

	
	 

	
	 

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
		<strong>
		
		
		
			
				
				
					<a href="/cgi/reprint/278/7/4385">
		<strong>Full Text</strong> (PDF)</a>
				
			
		
		</strong>
		</td></tr>
	
	

	
	
	

	
	
	

	
	





	
		

	
		

	
		
		

			


	

			

			
		
	

			
	  
	

			

			

			
	
	

	
		
	









	
		
	
		
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item"><strong>
			All Versions of this Article:<br>
		
			
					278/7/4385
				
		&nbsp;&nbsp;&nbsp;<font color="#006699"><em>most recent</em></font><br>
	

	
		
		
			<a href="/cgi/content/short/C200679200v1">
					C200679200v1</a>
			
		</strong></td></tr>
	

	





	

	 

	

	
	
		  
    

	







		
	
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;278/7/4385&return_type=article&return_url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385">
				Alert me when this article is cited</a></strong>
			</td></tr>
	

		
		

		
		

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/ctalert?alertType=correction&addAlert=correction&saveAlert=no&correction_criteria_value=278/7/4385&return_type=article&return_url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385">
				Alert me if a correction is posted</a></strong>
			</td></tr>
		










			
		
			
			
			
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
					<strong><a href="/cgi/citemap?id=jbc;278/7/4385">
					Citation Map</a></strong>
				</td></tr>
		
	

			
			
<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr><tr><td class="content_box_title" colspan="2">Services</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/mailafriend?url=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F278%2F7%2F4385&title=The+Fourth+Transmembrane+Segment+Forms+the+Interface+of+the+Dopamine+D2+Receptor+Homodimer">
				Email this article to a friend</a></strong>
			</td></tr>
			
			


	

	

		
		



			
			
			
		
	

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
		<strong>
		<a href="/cgi/search?qbe=jbc;C200679200&journalcode=jbc&minscore=5000">
		Similar articles in this journal</a>
		</strong>
		</td></tr>

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/external_ref?access_num=12496294&link_type=MED_NBRS">
				Similar articles in PubMed</a></strong>
			</td></tr>
		
	


		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/alerts/etoc">
				Alert me to new issues of the journal</a></strong>
			</td></tr>
		

		
		
	

		
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
			<strong><a href="/cgi/citmgr?gca=jbc;278/7/4385">
			Download to citation manager</a></strong>
			</td></tr>
		
		
	


	
		
	

	


	

	

		


	
	
	
		

	

	






	
		
<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr><tr><td class="content_box_title" colspan="2">PubMed</td></tr>
	<tr><td class="content_box_space_between_sections" colspan="2"><img alt="" width="200" height="1" src="/icons/spacer.gif"></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
				<strong><a href="/cgi/external_ref?access_num=12496294&link_type=PUBMED">
				PubMed Citation</a></strong>
			</td></tr>
		
	

	
		
		
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
							<strong><a target="_blank" href="/cgi/external_ref?access_num=Guo+W&link_type=AUTHORSEARCH">
							Articles by Guo, W.</a></strong>
						</td></tr>
				
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="" width="4" height="11" border="0" src="/icons/shared/misc/arrowTtrim.gif"></td><td class="content_box_item">
							<strong><a target="_blank" href="/cgi/external_ref?access_num=Javitch+JA&link_type=AUTHORSEARCH">
							Articles by Javitch, J. A.</a></strong>
						</td></tr>
				
			
		

		
	






	






	
		

	

		
			
		











	




	</td></tr></table>
</td></tr></table> 

					
					
	

<BR CLEAR=ALL>








	
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol278/issue7/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
	<TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
	<TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
	<TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
	<TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2003 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
